The effect of magnesium sulfate on large cerebral artery blood flow in preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 17, Issue 3, 2005, Pages 187-192

  Hatab, Mustapha R ^a,b   Zeeman, Gerda G ^a   Twickler, Diane M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cerebral blood flow; Magnetic resonance imaging; Preeclampsia

Indexed keywords

MAGNESIUM SULFATE;

ADULT; ARTERY DIAMETER; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CEREBRAL ARTERY; PREECLAMPSIA; PRIORITY JOURNAL; VASOCONSTRICTION; VELOCITY ENCODED PHASE CONTRAST NUCLEAR MAGNETIC RESONANCE IMAGING; WILCOXON SIGNED RANKS TEST;

ADULT; ANTICONVULSANTS; BLOOD FLOW VELOCITY; CEREBRAL ARTERIES; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MAGNESIUM SULFATE; MAGNETIC RESONANCE IMAGING; PRE-ECLAMPSIA; PREGNANCY; PULSATILE FLOW; TELENCEPHALON;

EID: 22244440545     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050500073050     Document Type: Article

References (24)

1. American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. Practice Bulletin No 33, January 2002.
2. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:201-205.
3. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-1463.
4. The Magpie Trial Collaborative Group. Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomized placebo-controlled trial. Lancet 2002;359:1877-1890.
5. Belfort MA, Anthony JA, Saade GR, et al. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003;348:304-311.
6. Lewis LK, Hinshaw DB, Will AD, et al. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988;30:59-64.
7. Trommer BL, Homer O, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988;19:326-329.
8. Belfort MA, Grunewald C, Saade GR, et al. Preeclampsia may cause both overperfusion and underperfusion of the brain. Acta Obstet Gynecol Scand 1999;78:586-591.
9. Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy. Arch Neurol 1988;45:1078-1083.
10. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183(1):S1-S22.
11. Morriss MC, Twickler DM, Hatab MR, et al. Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia. Obstet Gynecol 1997;89:561-568.
12. Brown CE, Purdy P, Cunningham FG. Head computed tomographic scans in women with eclampsia. Am J Obstet Gynecol 1988;159:915-920.
13. Schwartz RB, Jones KM, Kolina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging and SPECT imaging in 14 cases. AJR 1992;159:379-383.
14. Enzmann DR, Marks MP, Pelc NJ. Comparison of cerebral artery blood flow measurements with gated cine and ungated phase-contrast techniques. J Magn Reson Imaging 1993;3: 705-712.
15. Williams KP, McLean C. Peripartum changes in maternal cerebral blood flow velocity in normotensive and preeclamptic patients. Obstet Gynecol 1993 Sep;82(3):334-337.
16. Belfort MA, Moise KJ Jr. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992;167(3):661-666.
17. Belfort MA, Saade GR, Moise KJ Jr. The effect of magnesium sulfate on maternal and fetal blood flow in pregnancy-induced hypertension. Acta Obstet Gynecol Scand 1993;72(7):526-530.
18. Naidu S, Payne AJ, Moodley J, et al. Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound. British J Obstet Gynecol 1996;103:111-116.
19. Giller CA, Hatab MR, Giller AM. Estimation of vessel flow and diameter during cerebral vasospasm using transcranial Doppler indices. Neurosurgery. 1998 May;42(5):1076-1081.
20. Hatab MR, Giller CA, Clarke GD. Evaluation of cerebral arterial flow with transcranial Doppler ultrasound: theoretical development and phantom studies. Ultrasound Med Biol 1997;23(7):1025-1031.
21. Hinchley, J, Chaves, C, Appignani B, et al. A reversible posterior leukoencephanlopathy syndrome. N Engl J Med 1996;334:494-500.
22. Chester EM, Agamanolis DP, Bank, BQ, et al. Hypertensive encephalopathy: a clinicopathological study of 20 cases. Neurology 1978;28:928-939.
23. Pritchard JA. The use of the magnesium ion in the management of eclamptogenic toxemias. Surgery, Gynecology & Obstetrics 1955;100(2):131-140.
24. Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 1984;150:728-733.